Daniel W. Young

Dan Young assists clients in patent prosecution and IP due diligence primarily in the areas of biotechnology, cellular and molecular biology, genomics, biomedical engineering, and clean energy technologies.

Representative Matters

Assisted corporate biotech fund with IP due diligence analysis of startup biopharmaceutical company.
Assisted a start-up molecular diagnostics company with developing and implementing an overall patent strategy to help position it for a Series A financing.
Prepared and filed a series of patent applications for a local university to capture innovations relating to a therapeutic vaccine technology.

Previous Experience

A recipient of a Novartis Presidential Post-Doctoral Fellowship, Dan did his post-doctoral research at the Novartis Institute for BioMedical Research and the Department of Systems Biology at Harvard Medical School. During this time, he was involved in an image-based genome-wide RNAi screen, and developed computational approaches to profile small-molecule libraries using multidimensional cell-based assays for lead discovery and characterization. Dan’s doctoral work focused on understanding molecular mechanisms of tissue-specific gene regulation. During his master’s studies, he investigated the poroelastic material properties of bone tissue.

Before entering graduate school, Dan worked for several years as a mechanical engineer in the Hydraulics Laboratory at FMGlobal Research and as a licensed engineering officer in the United States Merchant Marine.

Professional and Civic Activities

Boston Patent Law Association

Chair of the Activities and Public Relations Committee

Pioneer Valley Life Sciences Institute

Business Advisory Board Member

Worcester Polytechnic Institute Venture Forum

Vice Chair of the Program Committee
Co-Chair of the 5 Minute Pitch Contest

Honors and Awards

Sigma Xi

Phi Delta Phi

Also Noteworthy

Dan is co-inventor of a U.S. patent related to microscopic image analysis technology, and has co-authored more than 35 scientific research and review articles, including in Nature, Nature Chemical Biology, Nature Reviews Genetics, Nature Reviews Drug Discovery, and Proceedings of the National Academy of Sciences. One of Dan’s articles was voted “Must Read” by the Faculty of 1000 Biology.